Global Osteoporosis Market, Patients, Companies & Forecast (1)

1
(No Transcript)
2
Table of Contents
1. Executive Summary 2. Worldwide Osteoporosis
Patients Population Analysis 2.1 Worldwide
Osteoporosis Patients Population (2010
2019) 2.2 Worldwide Hip Fracture Patients
Population (2010 2019) 3. Worldwide
Osteoporosis Market (2010 2019)

3
Continue (www.renub.com)
4. Worldwide Osteoporosis Share
Analysis 4.1 Worldwide Osteoporosis Patients
Population Share (2010 2019)
4.2 Worldwide Hip Fracture Patients Population
Share (2010 2019) 4.3 Worldwide
Osteoporosis Market Share (2010 2019)
4.4 Worldwide Osteoporosis Drugs Company Market
Share (2010 2019)
4
Continue (www.renub.com)

5. India 5.1 India Osteoporosis Patients
Population (2010 2019) 5.2 India Hip Fracture
Patients Population (2010 2019) 5.3 India
Osteoporosis Market (2010 2019) 5.4 Level of
Awareness 5.5 Fracture Registries 5.6 Government
Policies 5.7 Guidelines 5.8 Reimbursement of
Medication
5
Continue (www.renub.com)
6. China 6.1 China Osteoporosis Patients
Population (2010 2019) 6.2 China Hip
Fracture Patients Population (2010 2019) 6.3
China Osteoporosis Market (2010 2019) 6.4
Level of Awareness 6.5 Fracture
Registries 6.6 Government Policies 6.7
Guidelines 6.8 Reimbursement of Medication

6
Continue (www.renub.com)
7. Japan 7.1 Japan Osteoporosis Patients
Population (2010 2019) 7.2 Japan Hip
Fracture Patients Population (2010 2019) 7.3
Japan Osteoporosis Market (2010 2019) 7.4
Level of Awareness 7.5 Fracture
Registries 7.6 Government Policies 7.7
Guidelines 7.8 Reimbursement of Medication
7
Continue (www.renub.com)
8. Korea 8.1 Korea Osteoporosis Patients
Population (2010 2019) 8.2 Korea Hip
Fracture Patients Population (2010 2019) 8.3
Korea Osteoporosis Market (2010 2019) 8.4
Level of Awareness 8.5 Fracture
Registries 8.6 Government Policies 8.7
Guidelines 8.8 Reimbursement of Medication
8
Continue (www.renub.com)
9 Brazil 9.1 Brazil Osteoporosis
Patients Population (2010 2019) 9.2
Brazil Hip Fracture Patients Population (2010
2019) 9.3 Brazil Osteoporosis Market (2010
2019) 9.4 Level of Awareness 9.5
Guidelines Policy 9.6 Reimbursement Policy
9
Continue (www.renub.com)
10. Russia 10.1 Russia Osteoporosis
Patients Population (2010 2019) 10.2 Russia
Hip Fracture Patients Population (2010 2019)
10.3 Russia Osteoporosis Market (2010 2019)
10.4 Level of Awareness 10.5 Government
Policy 10.6 Guidelines 10.7 Reimbursement
10
Continue (www.renub.com)
11. United Kingdom 11.1 United Kingdom
Osteoporosis Patients Population (2010
2019) 11.2 United Kingdom Hip Fracture
Patients Population (2010 2019) 11.3
United Kingdom Osteoporosis Market (2010 2019)
11.4 Guidelines 11.5 Reimbursement Policy
11
Continue (www.renub.com)
12. France 12.1 France Osteoporosis
Patients Population (2010 2019)
12.2 France Hip Fracture Patients Population
(2010 2019) 12.3 France
Osteoporosis Market (2010 2019) 12.4
Guidelines 12.5 Reimbursement Policy
12
Continue (www.renub.com)
13. Germany 13.1 Germany Osteoporosis
Patients Population (2010 2019)
13.2 Germany Hip Fracture Patients Population
(2010 2019) 13.3 Germany
Osteoporosis Market (2010 2019) 13.4
Guidelines 13.5 Reimbursement Policy
13
Continue (www.renub.com)
14. United States 14.1 United States
Osteoporosis Patients Population (2010
2019) 14.2 United States Hip Fracture
Patients Population (2010 2019)
14.3 United States Osteoporosis Market (2010
2019) 14.4 Policy 14.5 Guidelines 14.6
Reimbursement Policy
14
Continue (www.renub.com)
15. Growth Driver 15.1 Widespread Vitamin D
Deficiency Low Calcium Intake 15.2 Globally
Increasing Ageing Population Life
Expectancy 16. Challenges 16.1 Lack of
Reimbursement / Other Restrictions for
Reimbursement 16.2 Limited Access of Diagnostic
Tools Low Levels of Public and Health
Professional Awareness 16.3 Lack of Government
Osteoporosis Policy, Guidelines
National Health Priority in Asia Pacific Countries
15
Continue (www.renub.com)

• Key Players Osteoporosis Drugs Sales Forecast
• 17.1 Merck Osteoporosis Drugs Sales (2010 2019)
  
• 17.2 Sanofi Osteoporosis Drugs Sales (2010
  2019)
• 17.3 Novartis Osteoporosis Drugs Sales (2010
  2019)
• 17.4 Eli Lilly Osteoporosis Drugs Sales (2010
  2019)
• 17.5 Amgen Osteoporosis Drugs Sales (2010 2019)

16
Order Form
Scan and e-mail this page to info_at_renub.com,
alternatively one can also write the Contact
Information in an e-mail and mail it. Else you
can also fax this form to 91-120-424-9780
Questions? Please call
1-678-302-0700 (USA)
91-120-421-9822 (India), ,91-120-424-9780
or mail to info_at_renub.com
17
Format
Report Title Global Osteoporosis Market,
Patients, Companies Forecast
For More Details
http//www.renub.com/global-osteoporosis-market-pa
tients-companies-and-forecast-483-p.php
Single User (Email from Publisher) Hard Copy (Mail Delivery) CD Rom (Mail Delivery) Global Site License (Multiple User License)
US 1100 US 1200 US 1200 US 1,800
18
For ordering this report Three easy ways to
place your order

• Order online by Credit Card (Visa, MasterCard,
  etc.)
• http//www.renub.com/global-osteoporosis-market-pa
  tients-companies-and-forecast-483-p.php

19
Bank Details

• Account Name Renub Research
• A/C No. 109102000023296
• Name of Bank IDBI Bank Ltd.
• Swift Code IBKLINBB010
• Bank Address 4th Floor
• Indian Red Cross Building
• 1 Red Cross Road
• Opposite Parliament Street
• New Delhi 110001
• India

20
Contact Information
  First Name
Last Name Email Job Title
Company Address City Postal/Zip Code
Country Phone Mobile Fax Report
Format Your message
21
Order by Check

• Please post the check accompanied by this form,
  to
• Company Address Renub Research
• 1st Floor,
• C-86, Sector-10
• Noida - 201301
• Uttar Pradesh
• India
• Phone
  91-120-421-9822, 424-9780
• For free Sample copy report or to view any of our
  sample work please contact us at info_at_renub.com
  or call 91-120-421-9822 (India), 1-678-302-0700
  (USA)